There are 3161 resources available
1234P - Stage migration in resectable NSCLC
Presenter: Guus Heuvel
Session: Poster session 04
1235P - Pathologic response as a surrogate endpoint for event-free survival in neo-adjuvant immunotherapy trials of resectable non-small cell lung cancer: A subgroup analysis
Presenter: Nancy Huang
Session: Poster session 04
1236P - ctDNA-Lung-Detect: Profiling of non-shedding ctDNA early stage resected non-small cell lung cancers
Presenter: Sam Khan
Session: Poster session 04
1237P - Association of LRRC15 protein expression with 5-year survival in lung adenocarcinoma patients
Presenter: Jessie Woon
Session: Poster session 04
1238TiP - Combining immunotherapy with Trop2 ADc in early stage non-small cell lung cancer (CITADEL)
Presenter: Siu Ching Li
Session: Poster session 04
1244P - Association of tumor-draining lymph node metastatic patterns and neoadjuvant immunochemotherapy effectiveness in resectable non-small cell lung cancer
Presenter: Yu-heng Zhou
Session: Poster session 05
1245P - Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy vs. neoadjuvant chemotherapy in lung cancer treatment: A mixed method meta-analysis based on global randomized controlled trials
Presenter: Yiyang Li
Session: Poster session 05
Resources:
Abstract
1246P - PIT-3: A multicenter phase II trial of erlotinib induction followed by surgery in stage IIIA (N2) EGFR mutated non-small cell lung cancer
Presenter: Kazuya Takamochi
Session: Poster session 05
1247P - Radiotherapy (RT) patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients (pts) with Stage III unresectable non-small cell lung cancer (UR-NSCLC) treated with durvalumab (D) after chemoradiotherapy (CRT)
Presenter: Andrea Riccardo Filippi
Session: Poster session 05